| Literature DB >> 24809141 |
Rey Jesús Romero, Jonathan Kirsch Arad, Radomir Kosanovic, Julie Lamoureux, Anthony Michael Gonzalez.
Abstract
BACKGROUND AND OBJECTIVES: Minimally invasive surgery fellowship programs have been created in response to advancements in technology and patient's demands. Single-incision laparoscopic cholecystectomy (SILC) is a technique that has been shown to be safe and feasible, but this appears to be the case only for experienced surgeons. The purpose of this study is to evaluate the impact of minimally invasive surgery fellow participation during SILC.Entities:
Mesh:
Year: 2014 PMID: 24809141 PMCID: PMC3939348 DOI: 10.4293/108680813x13693422520765
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Differences in Demographic Characteristics, Comorbidities, and Indication for Surgery for Both Group 1 and Group 2
| Group 1 (attending only) (n = 142) | Group 2 (with fellow) (n = 87) | Test | ||
|---|---|---|---|---|
| Demographic characteristics | ||||
| Female | 111(78.2%) | 70 (80.5%) | χ21 | .679 |
| Male | 31 (21.8%) | 17 (19.5%) | ||
| Mean age (y) | 43.8 ± 14.2 (range, 19–84) | 47.5 ± 15.0 (range, 18–87) | .061 | |
| Comorbidities | ||||
| Mean BMI (kg/m2) | 28.9 ± 5.5 (range, 18.7–41.9) | 29.9 ± 6.1 (range, 16.4–51.4) | .222 | |
| Mean ASA score | 1.65 ± 0.64 | 1.86 ± 0.68 | χ21 | |
| Diabetes mellitus | 8 (5.6%) | 3 (3.4%) | χ21 | .448 |
| Hypertension | 22 (15.5%) | 16 (18.4%) | χ21 | .567 |
| Cardiovascular disease | 6 (4.2%) | 4 (4.6%) | χ21 | .885 |
| Hypothyroidism | 8 (5.6%) | 5 (5.7%) | χ21 | .975 |
| Gastroesophageal reflux disease | 20 (14.0%) | 15 (17.2%) | χ21 | .527 |
| Pulmonary disease | 6 (4.2%) | 9 (10.3%) | χ21 | .069 |
| Previous abdominal surgery | 52 (36.6%) | 38 (43.6%) | χ21 | .288 |
| Previous upper abdominal surgery | 5 (3.5%) | 6 (6.9%) | χ21 | .238 |
| Indication for surgery | ||||
| Symptomatic gallbladder stones | 110 (77.4%) | 64 (73.5%) | χ24 | .061 |
| Acute cholecystitis | 11 (7.7%) | 4 (4.6%) | ||
| Biliary dyskinesia | 10 (7.0%) | 14 (16.0%) | ||
| Polyps | 8 (5.6%) | 1 (1.1%) | ||
| Choledocholithiasis/biliary pancreatitis | 3 (2.1%) | 4 (4.6%) |
Kruskal-Wallis rank test.
Differences in Outcomes for Both Group 1 and Group 2
| Outcome | Group 1 (attending only) (n = 142) | Group 2 (with fellow) (n = 87) | Test | |
|---|---|---|---|---|
| Mean surgical time (min) | 34.4 ± 11.4 (range, 13–73) | 46.8 ± 16.0 (range, 22–102) | <.001 | |
| Mean hospital length of stay (d) | 0.89 ± 0.32 (range, 0.5–2) | 1.01 ± 0.40 (range, 0.5–4) | χ21 | .027 |
| Simultaneous procedures | 5 (3.5%) | 3 (3.4%) | χ21 | .977 |
| Cholangiogram | 11 (7.7%) | 13 (14.9%) | χ21 | .834 |
| ERCP[ | 4 (2.8%) | 4 (4.6%) | χ21 | .476 |
| Intraoperative complications | 0 | 0 | ||
| Postoperative complications | 3 (2.1%) | 0 | χ21 | .172 |
Satterthwaite correction for unequal variances.
Kruskal-Wallis rank test.
ERCP = endoscopic retrograde cholangiopancreatography.